Bylvay missed the study’s primary objective of showing an improvement in native liver survival rates compared to placebo.

The drugmaker said efficacy and safety data didn’t support further development of the drug, amlitelimab, for atopic ...

The country’s Financial Services Commission said it will bring forward the introduction of the cash deposit rule to the end ...

The two U.S.-based mathematicians have become the first Chinese nationals to earn the honor considered math’s equivalent of ...

The Yemeni militants have set up a standoff in one of the world’s most vital waterways with its threats against Red Sea oil ...

The president has grown skeptical of diplomacy and is in “revenge mode” against Tehran, according to a senior administration ...

Japan’s consumer inflation rose at a slightly faster pace in June with oil and food costs being the key factors affecting ...

Xi confidant leads fevered effort for domestic alternatives to win AI race. Chinese AI companies get warned that anyone who ...

Concerns about artificial-intelligence spending shaved roughly $890 billion in market value from the Magnificent Seven on ...

The country’s incoming commander in chief has resisted the rigid, bureaucratic decision-making in the armed forces.

The president’s proposed use of an obscure Depression-era law shows courts and Congress haven’t curbed Trump’s ambition to ...

Health is kind of the new wealth in China,” said one athletic apparel executive.